Droia Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 9

Professionals

  • Investments
  • 37

  • Portfolio
  • 20

  • Exits
  • 6

Exits

Droia Ventures General Information

Description

Founded in 2011, Droia Oncology Ventures is a venture capital firm based in Meise, Belgium. The firm has an additional office in Luxembourg, Luxembourg. The firm focuses on the development of oncology therapies and early-stage drug development companies.

Contact Information

Website
www.droiaventures.com
Year Founded
2011
Investor Status
Actively Seeking New Investments
Trade Association
Belgian Venturing Association (BVA)
Primary Investor Type
Venture Capital
Primary Office
  • Da Vincilaan 1
  • 1930 Zaventem
  • Belgium
+32 02 000 00 00

Droia Ventures Investments (37)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Hyku 19-Sep-2023 Seed Round 0000 Biotechnology Startup 00000000 000 0000000 00.0
Actio Biosciences 12-Sep-2023 00000 00000 0000 Drug Discovery Generating Revenue 000000 0000000000 00.0
QurAlis 09-Mar-2023 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 000 000000
Volastra 03-Feb-2023 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000 000000
Mahzi Therapeutics 11-Nov-2022 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 000 000000
Actio Biosciences 28-Jul-2022 0000 00000 000 Drug Discovery Generating Revenue
Vicinitas Therapeutics 28-Jul-2022 00000 00000 0000 Drug Discovery Startup 000000 0000000000 00.0
Summation Bio 04-Apr-2022 00000 00000 000.00 Biotechnology Startup 000 000000
Ambagon Therapeutics 05-Jan-2022 Early Stage VC 0000 Drug Discovery Clinical Trials - General 000000000 0000000
Muna Therapeutics 09-Jul-2021 Early Stage VC 000.00 Drug Discovery Generating Revenue 000 000000
You’re viewing 10 of 37 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Droia Ventures Exits (6)

Company Name Exit Date Exit Type Exit Size
Aura Biosciences 02-Nov-2021 IPO 000.00
Cyteir Therapeutics 18-Jun-2021 000 00000
Tusk Therapeutics 27-Sep-2018 000000000000000000 00000
NormOxys 01-Sep-2018 000 00 00000000
Arcus Biosciences 15-Mar-2018 IPO 00000
PX Biosolutions 01-Aug-2016 Out of Business
To view Droia Ventures’s complete exits history, request access »

Droia Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Droia Ventures Team (22)

Name Title Deals Funds Boards Office
Matthias De Witte Chief Financial Officer, General Counsel and Partner 0 Zaventem, Belgium
Matthias Van Woensel Ph.D Partner 0 0 0 Zaventem, Belgium
Sandra Schoors Ph.D Partner 0 Zaventem, Belgium
Lenny Steenhuyse Principal Zaventem, Belgium
Luc Verelst Co-Founder & Chairman 0 0 0 Zaventem, Belgium
You’re viewing 5 of 22 team members. Get the full list »

Droia Ventures Co-Investors (103)

Name With Exits Lead Partner Series Industry
Polaris Partners 6 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
EQT Life Sciences 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
You’re viewing 5 of 103 co-investors. Get the full list »